Common use of DESCRIPTION OF THE WARRANTS Clause in Contracts

DESCRIPTION OF THE WARRANTS. We may issue warrants to purchase debt securities, preferred stock or common stock. We may offer warrants separately or together with one or more additional warrants, debt securities, shares of preferred stock or common stock, or any combination of those securities in the form of units, as described in the applicable prospectus supplement. If we issue warrants as part of a unit, the prospectus supplement will specify whether those warrants may be separated from the other securities in the unit prior to the warrants’ expiration date. We may issue the warrants under warrant agreements to be entered into between us and a bank or trust company, as warrant agent, all as described in the prospectus supplement. If we issue the warrants under warrant agreements, the warrant agent will act solely as our agent in connection with the warrants and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants. We will describe the particular terms of any warrants that we offer in the prospectus supplement relating to those warrants. Those terms may include the following: · the specific designation and aggregate number of warrants, and the price at which we will issue the warrants; · the currency or currency units in which the offering price, if any, and the exercise price are payable; · the date on which the right to exercise the warrants will begin and the date on which the right will expire or, if the warrants are not continuously exercisable throughout that period, the specific date or dates on which they are exercisable; · whether the warrants will be issued in fully registered form or bearer form, in definitive or global form or in any combination of these forms; · any applicable material United States federal income tax considerations; · the identity of the warrant agent, if any, for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents; · the designation, aggregate principal amount, currency, denomination and terms of any debt securities that may be purchased upon exercise of the warrants; · the designation, amount, currency, denominations and terms of any preferred stock or common stock purchasable upon exercise of the warrants; · if applicable, the designation and terms of the debt securities, preferred stock or common stock with which the warrants are issued and the number of warrants issued with each security; · if applicable, the date from and after which the warrants and the related debt securities, preferred stock or common stock will be separately transferable; · the principal amount of debt securities or the number of shares of preferred stock or common stock purchasable upon exercise of any warrant and the price at which those shares may be purchased; · provisions for changes to or adjustments in the exercise price; · if applicable, the minimum or maximum number of warrants that may be exercised at any one time; · information with respect to any book-entry procedures; · any antidilution provision of the warrants; · any redemption or call provisions; and · any additional terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants. Our Outstanding Warrants

Appears in 2 contracts

Samples: ir.moleculin.com, ir.moleculin.com

AutoNDA by SimpleDocs

DESCRIPTION OF THE WARRANTS. We may issue warrants to for the purchase debt securitiesof our common stock, preferred stock or common stockdebt securities or any combination thereof. We Warrants may offer warrants separately be issued independently or together with one or more additional warrantsour common stock, debt securities, shares of preferred stock or common stock, or any combination of those debt securities in the form of units, as described in the applicable prospectus supplement. If we issue warrants as part of a unit, the prospectus supplement will specify whether those warrants and may be separated attached to or separate from the other securities in the unit prior to the warrants’ expiration dateany offered securities. We may issue the Each series of warrants will be issued under a separate warrant agreements agreement to be entered into between us and a bank or trust company, as warrant agent. This summary of some provisions of the warrants is not complete. For the terms of a particular series of warrants, all as described in you should refer to the prospectus supplement. If we issue the supplement for that series of warrants under warrant agreements, and the warrant agent will act solely as our agent in connection with the warrants and will not assume any obligation or relationship of agency or trust agreement for or with any holders or beneficial owners of warrantsthat particular series. We will describe the The particular terms of any issue of warrants that we offer will be described in the prospectus supplement relating to those warrantsthe issue. Those terms may include include: • the following: · the specific designation title and aggregate number of such warrants, ; • the number of shares of common stock or preferred stock purchasable upon the exercise of warrants to purchase such shares and the price at which we will issue such number of shares may be purchased upon such exercise; • the warrantsdesignation, stated value and terms (including, without limitation, liquidation, dividend, conversion and voting rights) of the series of preferred stock purchasable upon exercise of warrants to purchase preferred stock; · the currency or currency units in which the offering price, if any, principal amount of debt securities that may be purchased upon exercise of a debt warrant and the exercise price are payablefor the warrants, which may be payable in cash, securities or other property; · the date on which the right to exercise the warrants will begin commence and the date on which the right will expire or, if the warrants are not continuously exercisable throughout that period, the specific date or dates on which they are exercisableexpire; · whether the warrants will be issued in fully registered form or bearer form, in definitive or global form or in any combination of these forms; · any applicable material United States federal Federal income tax considerations; · the identity of the warrant agent, if any, for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents; · the designation, aggregate principal amount, currency, denomination and terms of any debt securities that may be purchased upon exercise of consequences applicable to the warrants; · the designation, amount, currency, denominations and terms of any preferred stock or common stock purchasable upon exercise of the warrants; · if applicable, the designation and terms of the debt securities, preferred stock or common stock with which the warrants are issued and the number of warrants issued with each security; · if applicable, the date from and after which the warrants and the related debt securities, preferred stock or common stock will be separately transferable; · the principal amount of debt securities or the number of shares of preferred stock or common stock purchasable upon exercise of any warrant and the price at which those shares may be purchased; · provisions for changes to or adjustments in the exercise price; · if applicable, the minimum or maximum number of warrants that may be exercised at any one time; · information with respect to any book-entry procedures; · any antidilution provision of the warrants; · any redemption or call provisions; and · any additional terms of the warrants, including terms, procedures procedures, and limitations relating to the exchange exchange, exercise and exercise settlement of the warrants. Our Outstanding WarrantsHolders of equity warrants will not be entitled: • to vote, consent or receive dividends; • receive notice as stockholders with respect to any meeting of stockholders for the election of our directors or any other matter; or • exercise any rights as stockholders. Debt warrant certificates may be exchangeable for new debt warrant certificates of different denominations. Debt warrants may be exercised at the corporate trust office of the warrant agent or any other office indicated in the prospectus supplement. Prior to the exercise of their debt warrants, holders of debt warrants will not have any of the rights of holders of the debt securities purchasable upon exercise and will not be entitled to payment of principal or any premium, if any, or interest on the debt securities purchasable upon exercise.

Appears in 1 contract

Samples: Nominating Agreement

DESCRIPTION OF THE WARRANTS. We may issue warrants to purchase debt securities, preferred stock or common stock. We may offer warrants separately or together with one or more additional warrants, debt securities, shares of preferred stock or common stock, or any combination of those securities in the form of units, as described in the applicable prospectus supplement. If we issue warrants as part of a unit, the prospectus supplement will specify whether those warrants may be separated from the other securities in the unit prior to the warrants’ expiration date. We may issue the warrants under warrant agreements to be entered into between us and a bank or trust company, as warrant agent, all as described in the prospectus supplement. If we issue the warrants under warrant agreements, the warrant agent will act solely as our agent in connection with the warrants and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants. We will describe the particular terms of any warrants that we offer in the prospectus supplement relating to those warrants. Those terms may include the following: · the specific designation and aggregate number of warrants, and the price at which we will issue the warrants; · the currency or currency units in which the offering price, if any, and the exercise price are payable; · the date on which the right to exercise the warrants will begin and the date on which the right will expire or, if the warrants are not continuously exercisable throughout that period, the specific date or dates on which they are exercisable; · whether the warrants will be issued in fully registered form or bearer form, in definitive or global form or in any combination of these forms; · any applicable material United States federal income tax considerations; · the identity of the warrant agent, if any, for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents; · the designation, aggregate principal amount, currency, denomination and terms of any debt securities that may be purchased upon exercise of the warrants; · the designation, amount, currency, denominations and terms of any preferred stock or common stock purchasable upon exercise of the warrants; · if applicable, the designation and terms of the debt securities, preferred stock or common stock with which the warrants are issued and the number of warrants issued with each security; · if applicable, the date from and after which the warrants and the related debt securities, preferred stock or common stock will be separately transferable; · the principal amount of debt securities or the number of shares of preferred stock or common stock purchasable upon exercise of any warrant and the price at which those shares may be purchased; · provisions for changes to or adjustments in the exercise price; · if applicable, the minimum or maximum number of warrants that may be exercised at any one time; · information with respect to any book-entry procedures; · any antidilution provision of the warrants; · any redemption or call provisions; and · any additional terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants. Our Outstanding WarrantsEach warrant will entitle the holder thereof to purchase such number of shares of common stock or preferred stock or other securities at the exercise price as will in each case be set forth in, or be determinable as set forth in, the applicable prospectus supplement. Warrants may be exercised at any time up to the close of business on the expiration date set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void. Warrants may be exercised as set forth in the applicable prospectus supplement relating to the warrants offered thereby. Upon receipt of payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement, we will, as soon as practicable, forward the purchased securities. If less than all of the warrants represented by the warrant certificate are exercised, a new warrant certificate will be issued for the remaining warrants.

Appears in 1 contract

Samples: ir.moleculin.com

AutoNDA by SimpleDocs

DESCRIPTION OF THE WARRANTS. We may issue warrants to purchase debt securities, preferred stock or common stock. We may offer warrants separately or together with one or more additional warrants, debt securities, shares of preferred stock or common stock, or any combination of those securities in the form of units, as described in the applicable prospectus supplement. If we issue warrants as part of a unit, the prospectus supplement will specify whether those warrants may be separated from the other securities in the unit prior to the warrants’ expiration date. We may issue the warrants under warrant agreements to be entered into between us and a bank or trust company, as warrant agent, all as described in the prospectus supplement. If we issue the warrants under warrant agreements, the warrant agent will act solely as our agent in connection with the warrants and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants. We will describe the particular terms of any warrants that we offer in the prospectus supplement relating to those warrants. Those terms may include the following: · the specific designation and aggregate number of warrants, and the price at which we will issue the warrants; · the currency or currency units in which the offering price, if any, and the exercise price are payable; · the date on which the right to exercise the warrants will begin and the date on which the right will expire or, if the warrants are not continuously exercisable throughout that period, the specific date or dates on which they are exercisable; · whether the warrants will be issued in fully registered form or bearer form, in definitive or global form or in any combination of these forms; · any applicable material United States federal income tax considerations; · the identity of the warrant agent, if any, for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents; · the designation, aggregate principal amount, currency, denomination and terms of any debt securities that may be purchased upon exercise of the warrants; · the designation, amount, currency, denominations and terms of any preferred stock or common stock purchasable upon exercise of the warrants; · if applicable, the designation and terms of the debt securities, preferred stock or common stock with which the warrants are issued and the number of warrants issued with each security; 18 · if applicable, the date from and after which the warrants and the related debt securities, preferred stock or common stock will be separately transferable; · the principal amount of debt securities or the number of shares of preferred stock or common stock purchasable upon exercise of any warrant and the price at which those shares may be purchased; · provisions for changes to or adjustments in the exercise price; · if applicable, the minimum or maximum number of warrants that may be exercised at any one time; · information with respect to any book-entry procedures; · any antidilution anti-dilution provision of the warrants; · any redemption or call provisions; and · any additional terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants. Our Outstanding WarrantsEach warrant will entitle the holder thereof to purchase such number of shares of common stock or preferred stock or other securities at the exercise price as will in each case be set forth in, or be determinable as set forth in, the applicable prospectus supplement. Warrants may be exercised at any time up to the close of business on the expiration date set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void. Warrants may be exercised as set forth in the applicable prospectus supplement relating to the warrants offered thereby. Upon receipt of payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement, we will, as soon as practicable, forward the purchased securities. If less than all of the warrants represented by the warrant certificate are exercised, a new warrant certificate will be issued for the remaining warrants.

Appears in 1 contract

Samples: ir.cnspharma.com

Time is Money Join Law Insider Premium to draft better contracts faster.